Skip to main content

Needle-free, painless vaccinations may become a reality thanks to MucoJet

A painless way to give vaccines
No one likes getting vaccinated but it’s a lot better than getting sick. Putting aside the concerns some have about the supposed risks of vaccines, let’s recognize that they’ve saved millions of children from diseases in the United States alone, according to the Center for Disease Control. So vaccinations are pretty great.
Recommended Videos

Injections, however, are pretty damn painful, especially for tiny tots who are most at risk of disease. That might change within a decade though thanks to a needle-free device called the MucoJet that make vaccinations practically painless. Developed by researchers in Dorian Liepmann’s lab at the University of California, Berkeley, the pill-sized, 3D-printed device shoots a stream of vaccine into the tissue of the cheek.

To activate the MucoJet, a patient first need to squeeze the device together, creating a reaction and increasing pressure inside. The patient then holds the device on the inside of her cheek for about ten seconds, at which point the pressure breaks a membrane and shoots a concentrated stream of vaccine through a small nozzle.

The MucoJet is needle-free (and thus virtually painless) and may also be able to address viruses more effectively than conventional techniques, according to Kiana Aran, a professor of mechanical and bioengineering who developed the MucoJet while working in Liepmann’s lab.

“The majority of modern vaccines are injected intramuscularly or subcutaneously, although the majority of pathogens actually access the body via the mucosal surfaces,” she told Digital Trends. A few vaccines are administered through the mucosal surfaces — including oral polio and rotavirus vaccine but, Aran said, these have limited safety and utility since they contain live viral components. With MucoJet, the researchers think they may be able to design safer and more effective mucosal vaccines.

So far, the researchers have demonstrated a proof of concept, successfully delivering vaccine-size molecules to cells in the mouths of animals. A paper describing the device was published last week in the journal Science Translational Medicine. Future research will entail testing the MucoJet on larger animals, such as monkeys and pigs. The researchers think the product may come to market in the next five to ten years.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
The UK’s Wayve brings its AI automated driving software to U.S. shores
wayve ai automated driving us driver assist2 1920x1152 1

It might seem that the autonomous driving trend is moving at full speed and on its own accord, especially if you live in California.Wayve, a UK startup that has received over $1 billion in funding, is now joining the crowded party by launching on-road testing of its AI learning system on the streets of San Francisco and the Bay Area.The announcement comes just weeks after Tesla unveiled its Robotaxi at the Warner Bros Studios in Burbank, California. It was also in San Francisco that an accident last year forced General Motors’ robotaxi service Cruise to stop its operations. And it’s mostly in California that Waymo, the only functioning robotaxi service in the U.S., first deployed its fleet of self-driving cars. As part of its move, Wayve opened a new office in Silicon Valley to support its U.S. expansion and AI development. Similarly to Tesla’s Full-Self Driving (FSD) software, the company says it’s using AI to provide automakers with a full range of driver assistance and automation features.“We are now testing our AI software in real-world environments across two continents,” said Alex Kendall, Wayve co-founder and CEO.The company has already conducted tests on UK roads since 2018. It received a huge boost earlier this year when it raised over $1 billion in a move led by Softbank and joined by Microsoft and Nvidia. In August, Uber also said it would invest to help the development of Wayve’s technology.Just like Tesla’s FSD, Wayve’s software provides an advanced driver assistance system that still requires driver supervision.Before driverless vehicles can legally hit the road, they must first pass strict safety tests.So far, Waymo’s technology, which relies on pre-mapped roads, sensors, cameras, radar, and lidar (a laser-light radar), is the only of its kind to have received the nod from U.S. regulators.

Read more
Aptera’s 3-wheel solar EV hits milestone on way toward 2025 commercialization
Aptera 2e

EV drivers may relish that charging networks are climbing over each other to provide needed juice alongside roads and highways.

But they may relish even more not having to make many recharging stops along the way as their EV soaks up the bountiful energy coming straight from the sun.

Read more
Ford ships new NACS adapters to EV customers
Ford EVs at a Tesla Supercharger station.

Thanks to a Tesla-provided adapter, owners of Ford electric vehicles were among the first non-Tesla drivers to get access to the SuperCharger network in the U.S.

Yet, amid slowing supply from Tesla, Ford is now turning to Lectron, an EV accessories supplier, to provide these North American Charging Standard (NACS) adapters, according to InsideEVs.

Read more